2026-08-252026-08-25https://scholars.csmu.edu.tw/handle/123456789/16996Backgrounds: HER2 gene amplification and protein over-expression are important factors in predicting clinical sensitivity to anti-HER2 monoclonal antibody therapy in breast, gastric or gastro-oeso...(詳)卵巢癌是臺灣地區婦科癌症第二位(次於子宮頸癌)，每年新增約四百名婦女，致死率高居婦科癌症的首位，始終是國人婦女揮之不去的陰霾。標靶治療 (targeted therapy)是癌症治療的新紀元，...(詳)上皮卵巢癌原發黏液性卵巢癌標靶治療Epithelial ovarian cancermucinous ovarian cancertargeted therapyresearch project